Table 3.
Comparison of women with and without gestational diabetes after matching for age, body mass index (BMI), and age plus BMI, and adjustment for age and BMI
| Matched for age |
Matched for BMI |
Matched for age plus BMI |
||||
|---|---|---|---|---|---|---|
| Parameters | Non-GDM (n = 197) | GDM (n = 32) | Non-GDM (n = 188) | GDM (n = 31) | Non-GDM (n = 170) | GDM (n = 31) |
| Age (years) | 31.19 ± 0.30 | 32.1 ± 0.8 | 30.25 ± 0.34 | 32.32 ± 0.81 | 31.09 ± 0.33 | 32.32 ± 0.81 |
| BMI (kg/m2) | 24.13 ± 0.20 | 24.9 ± 0.6 | 23.79 ± 0.18 | 24.52 ± 0.52 | 23.87 ± 0.18 | 24.52 ± 0.52 |
| HbA1c (%) | 5.21 ± 0.02 | 5.35 ± 0.06 | 5.20 ± 0.03 | 5.35 ± 0.06 | 5.20 ± 0.03 | 5.35 ± 0.06 |
| 1HGCT (mg/dL) | 113.49 ± 1.66 | 160 ± 3** | 113.38 ± 1.67 | 158.73 ± 3.25** | 114.63 ± 1.80 | 158.73 ± 3.25** |
| Insulin (mU/mL) | 53.12 ± 3.12 | 120.7 ± 15.5** | 54.14 ± 3.21 | 122.64 ± 15.87** | 51.43 ± 3.22 | 122.64 ± 15.87** |
| T-APN (μg/mL) | 8.22 ± 0.42 | 5.5 ± 0.7** | 8.42 ± 0.44 | 5.5 ± 0.5** | 8.42 ± 0.46 | 5.5 ± 0.5** |
| HMW-APN (μg/mL) | 2.90 ± 0.10 | 2.4 ± 0.2 | 2.95 ± 0.11 | 2.46 ± 0.21 | 2.93 ± 0.11 | 2.46 ± 0.21 |
| CRP (μg/mL) | 4.07 ± 0.39 | 3.7 ± 0.6 | 4.13 ± 0.42 | 3.68 ± 0.57 | 4.10 ± 0.44 | 3.68 ± 0.57 |
| TNF-α (pg/mL) | 10.83 ± 0.25 | 10.6 ± 0.7 | 11.08 ± 0.31 | 10.43 ± 0.65 | 11.00 ± 0.28 | 10.43 ± 0.65 |
| IL-6 (pg/mL) | 2.48 ± 0.11 | 2.9 ± 0.6 | 2.7 ± 0.2 | 2.85 ± 0.59 | 2.50 ± 0.12 | 2.85 ± 0.59 |
| MCP-1 (pg/mL) | 61.64 ± 1.98 | 73.7 ± 10.7 | 62.7 ± 2.1 | 73.8 ± 11.9 | 62.79 ± 2.23 | 73.8 ± 11.9 |
**
Data are the mean ± SEM. **P < 0.001 compared with women without gestational diabetes.
GDM, gestational diabetes; 1HGCT, glucose levels 1 h after a 50-g glucose challenge test; T-APN, total adiponectin; HMW-APN, high molecular weight adiponectin; CRP, C-reactive protein; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1.